Open Access
Med Sci (Paris)
Volume 36, Number 3, Mars 2020
Page(s) 231 - 234
Section M/S Revues
Published online 31 March 2020
  1. Marant-Micallef C, Shield KD, Vignat J, et al. Nombre et fractions de cancers attribuables au mode de vie et à l’environnement en France métropolitaine en 2015: résultats principaux. Bull Epidémiol Hebd 2018 ; 21 : 442–448. [Google Scholar]
  2. Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst 2011 ; 103 : 1827–1839. [CrossRef] [PubMed] [Google Scholar]
  3. Mehanna H, Bryant TS, Babrah J, et al. Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV16 prevalence in the UK - a cross-sectional study. Clin Infect Dis 2019 ; 69 : 1296–1302. [CrossRef] [PubMed] [Google Scholar]
  4. Lazcano-Ponce E, Salmerón J, González A, et al. Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study. Salud Publica Mex 2018 ; 60 : 703–712. [CrossRef] [PubMed] [Google Scholar]
  5. Emmett S, Jenkins G, Boros S, et al. Low prevalence of human papillomavirus in oral cavity squamous cell carcinoma in Queensland. Australia. ANZ J Surg 2017 ; 87 : 714–719. [CrossRef] [Google Scholar]
  6. Kehm RD, Yang W, Tehranifar P, Terry MB. 40 Years of change in age - and stage-specific cancer incidence rates in US women and men. JNCI Cancer Spectr 2019; 3 : pkz038. [CrossRef] [PubMed] [Google Scholar]
  7. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003 ; 61 : 1115–1117. [CrossRef] [PubMed] [Google Scholar]
  8. Wotton CJ, Green J, Brown A, et al. Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women. Bone 2019 ; 124 : 69–74. [CrossRef] [PubMed] [Google Scholar]
  9. Watts NB, Grbic JT, Binkley N, et al. Invasive oral procedures and events in postmenopausal women with osteoporosis treated with denosumab for up to 10 years. J Clin Endocrinol Metab 2019 ; 104 : 2443–2452. [CrossRef] [PubMed] [Google Scholar]
  10. Eleutherakis-Papaiakovou E, Bamias A. Antiresorptive treatment-associated ONJ. Eur J Cancer Care 2017 ; 26 : [Google Scholar]
  11. Adornato MC, Morcos I, Rozanski J. The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc 2007 ; 138 : 971–977. [CrossRef] [PubMed] [Google Scholar]
  12. Pérez-Chaparro PJ, Gonçalves C, Figueiredo LC, et al. Newly identified pathogens associated with periodontitis: a systematic review. J Dent Res 2014 ; 93 : 846–858. [CrossRef] [PubMed] [Google Scholar]
  13. Meuric V, Le Gall-David S, Boyer E, et al. Signature of microbial dysbiosis in periodontitis. Appl Environ Microbiol 2017 ; 83 : e00462–e00417. [Google Scholar]
  14. Pussinen PJ, Alfthan G, Jousilahti P, et al. Systemic exposure to Porphyromonas gingivalis predicts incident stroke. Atherosclerosis 2007 ; 193 : 222–228. [CrossRef] [PubMed] [Google Scholar]
  15. Sen S, Chung M, Duda V, et al. Periodontal disease associated with aortic arch atheroma in patients with stroke or transient ischemic attack. J Stroke Cerebrovasc Dis 2017 ; 26 : 2137–2144. [CrossRef] [PubMed] [Google Scholar]
  16. Delbosc S, Rouer M, Alsac JM, et al. High-density lipoprotein therapy inhibits Porphyromonas gingivalis-induced abdominal aortic aneurysm progression. Thromb Haemost 2016 ; 115 : 789–799. [CrossRef] [PubMed] [Google Scholar]
  17. Peres MA, Macpherson LMD, Weyant RJ, et al. Oral diseases: a global public health challenge. Lancet 2019 ; 394 : 261–272. [CrossRef] [PubMed] [Google Scholar]
  18. Alaluusua S.. Aetiology of molar-incisor hypomineralisation: a systematic review. Eur Arch Paediatr Dent 2010 ; 11 : 53–58. [Google Scholar]
  19. Jedeon K, Houari S, Loiodice S, et al. Chronic exposure to bisphenol A exacerbates dental fluorosis in growing rats. J Bone Miner Res 2016 ; 31 : 1955–1966. [Google Scholar]
  20. Silva MJ, Scurrah KJ, Craig JM, et al. Etiology of molar incisor hypomineralization: a systematic review. Community Dent Oral Epidemiol 2016 ; 44 : 342–353. [CrossRef] [PubMed] [Google Scholar]
  21. Houari S, Picard E, Wurtz T, et al. Disrupted iron storage in dental fluorosis. J Dent Res 2019 ; 98 : 994–1001. [CrossRef] [PubMed] [Google Scholar]
  22. Chardin H, Mercier K, Frydman C, Vollmer N. Surface plasmon resonance imaging: a method to measure the affinity of the antibodies in allergy diagnosis. J Immunol Methods 2014 ; 405 : 23–28. [CrossRef] [PubMed] [Google Scholar]
  23. Porto-Mascarenhas EC, Assad DX, Chardin H, et al. Salivary biomarkers in the diagnosis of breast cancer: A review. Crit Rev Oncol Hematol 2017 ; 110 : 62–73. [CrossRef] [PubMed] [Google Scholar]
  24. Guerra EN, Acevedo AC, Leite AF, et al. Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer: a systematic review and meta-analysis. Oral Oncol 2015 ; 51 : 805–818. [CrossRef] [PubMed] [Google Scholar]
  25. Babajko S, Gayrard V, Houari S, et al. La sphère orale, cible et marqueur de l’exposition environnementale. I. Défauts du développement dentaire. Med Sci (Paris) 2020; 36 : 225–30. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.